IFN-α treatment reduced HIV-1 infection by 20-fold in the presence of OTOF, whereas it reduced HIV-1 infection by 6.7- to 9.4-fold in the absence of OTOF. The gene discussed is IFNA2; the disease is HIV-1 infection.